Peptide Companion
Back to catalog
Peptide Companion
single
Cognitive
Vial: 5 mg

Selank (5 mg Vial)

Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials. In Russian studies, intranasal Selank produced anxiolytic effects comparable to benzodiazepines without sedation or dependence potential. This educational protocol presents a once‑daily subcutaneous approach using practical dilution for accurate insulin‑syringe measurements.

Dose
0.25–0.5 mg per injection
Frequency
Once or twice daily
Timing
Morning and/or afternoon
Duration
4–8 weeks

Anxiolytic peptide. Reduces anxiety without sedation. Immune-modulating effects.

Dosing Schedule
WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2300 mcg18 units (0.18 mL)
Weeks 3–4500 mcg30 units (0.30 mL)
Supplies Needed
  • •Peptide Vials (Selank, 5 mg each):
  • •Insulin Syringes (U‑100):
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References

  • PubMed

    Clinical trial of Selank for generalized anxiety disorder (intranasal, human study)

    View source

  • PubMed

    Selank for neurasthenia: 14-day clinical trial demonstrating anxiolytic and anti-asthenic effects (human study)

    View source

  • Hindawi BioMed Research

    Intranasal Selank administration review: neurobehavioral effects and clinical applications (review article)

    View source

  • Springer

    Primate studies: intranasal Selank eliminates anxiety behaviors with long-term effects (preclinical)

    View source

  • Springer

    Selank attenuates opioid withdrawal symptoms in animal models (preclinical dosing study)

    View source

  • CDC

    Vaccine administration best practices: subcutaneous injection technique and site selection

    View source

  • Cleveland Clinic

    Subcutaneous injection guide: technique, sites, and rotation principles

    View source

  • NCBI Bookshelf

    Clinical procedures: injection preparation, aseptic technique, and administration standards

    View source

  • CDC

    Injection safety guidelines: single-use devices, sharps disposal, and preventing unsafe practices

    View source

  • NIBSC

    Peptide storage guidelines: lyophilized and reconstituted stability considerations

    View source

  • PMC

    Pharmacologic review: subcutaneous drug delivery and absorption considerations

    View source

Educational content adapted from peptidedosages.com. Not medical advice.